226 related articles for article (PubMed ID: 34850262)
1. Recommendations for diagnosing STIC: a systematic review and meta-analysis.
Bogaerts JMA; Steenbeek MP; van Bommel MHD; Bulten J; van der Laak JAWM; de Hullu JA; Simons M
Virchows Arch; 2022 Apr; 480(4):725-737. PubMed ID: 34850262
[TBL] [Abstract][Full Text] [Related]
2. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol?
Mahe E; Tang S; Deb P; Sur M; Lytwyn A; Daya D
Int J Gynecol Pathol; 2013 Jul; 32(4):353-7. PubMed ID: 23722507
[TBL] [Abstract][Full Text] [Related]
3. Outcome and Management of Serous Tubal Intraepithelial Carcinoma Following Opportunistic Salpingectomy: Systematic Review and Meta-Analysis.
Ruel-Laliberté J; Kasasni SM; Oprea D; Viau M
J Obstet Gynaecol Can; 2022 Nov; 44(11):1174-1180. PubMed ID: 36099965
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC).
Saccardi C; Zovato S; Spagnol G; Bonaldo G; Marchetti M; Alessandrini L; Tognazzo S; Guerriero A; Vitagliano A; Laganà AS; Noventa M
Gynecol Oncol; 2021 Nov; 163(2):364-370. PubMed ID: 34465478
[TBL] [Abstract][Full Text] [Related]
5. Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer).
Seidman JD
Int J Gynecol Pathol; 2015 Mar; 34(2):112-20. PubMed ID: 25675178
[TBL] [Abstract][Full Text] [Related]
6. Serous tubal intra-epithelial carcinoma: what do we really know at this point?
Vang R; Shih IM
Histopathology; 2022 Nov; 81(5):542-555. PubMed ID: 35859323
[TBL] [Abstract][Full Text] [Related]
7. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
8. Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer.
Byun JM; Cho HJ; Lee DS; Yoon HK; Kim YN; Im DH; Kim DH; Lee KB; Sung MS; Jeong DH
Taiwan J Obstet Gynecol; 2023 Jan; 62(1):107-111. PubMed ID: 36720520
[TBL] [Abstract][Full Text] [Related]
9. Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO).
Stanciu PI; Ind TEJ; Barton DPJ; Butler JB; Vroobel KM; Attygalle AD; Nobbenhuis MAE
J Ovarian Res; 2019 May; 12(1):50. PubMed ID: 31128592
[TBL] [Abstract][Full Text] [Related]
10. A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers.
Cass I; Walts AE; Barbuto D; Lester J; Karlan B
Gynecol Oncol; 2014 Sep; 134(3):492-7. PubMed ID: 25026639
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review.
Patrono MG; Iniesta MD; Malpica A; Lu KH; Fernandez RO; Salvo G; Ramirez PT
Gynecol Oncol; 2015 Dec; 139(3):568-72. PubMed ID: 26407480
[TBL] [Abstract][Full Text] [Related]
12. Consensus based recommendations for the diagnosis of serous tubal intraepithelial carcinoma: an international Delphi study.
Bogaerts JMA; van Bommel MHD; Hermens RPMG; Steenbeek MP; de Hullu JA; van der Laak JAWM; ; Simons M
Histopathology; 2023 Jul; 83(1):67-79. PubMed ID: 36939551
[TBL] [Abstract][Full Text] [Related]
13. Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up.
Blok F; Dasgupta S; Dinjens WNM; Roes EM; van Beekhuizen HJ; Ewing-Graham PC
Gynecol Oncol; 2019 May; 153(2):326-334. PubMed ID: 30894273
[TBL] [Abstract][Full Text] [Related]
14. The association of serous tubal intraepithelial carcinoma with gynecologic pathologies and its role in pelvic serous cancer.
Koç N; Ayas S; Uygur L
Gynecol Oncol; 2014 Sep; 134(3):486-91. PubMed ID: 25038287
[TBL] [Abstract][Full Text] [Related]
15. Pathological findings following risk-reducing salpingo-oophorectomy in BRCA mutation carriers: A systematic review and meta-analysis.
Cheng A; Li L; Wu M; Lang J
Eur J Surg Oncol; 2020 Jan; 46(1):139-147. PubMed ID: 31521389
[TBL] [Abstract][Full Text] [Related]
16. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
[No Abstract] [Full Text] [Related]
17. Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis.
Li HX; Lu ZH; Shen K; Cheng WJ; Malpica A; Zhang J; Wei JJ; Zhang ZH; Liu J
Int J Clin Exp Pathol; 2014; 7(3):848-57. PubMed ID: 24696706
[TBL] [Abstract][Full Text] [Related]
18. A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany.
van der Ven J; Linz VC; Anic K; Schmidt MW; Loewe A; Krajnak S; Schmidt M; Kommoss S; Schmalfeldt B; Sehouli J; Hasenburg A; Battista MJ
Arch Gynecol Obstet; 2023 Aug; 308(2):527-534. PubMed ID: 36707423
[TBL] [Abstract][Full Text] [Related]
19. Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions.
Chien YW; Wang Y; Huang P; Lawson BC; Kolin DL; Chui MH; Vang R; Numan TA; Soong TR; Wang BG; Smith SA; Chen CL; Stone R; Douville C; Wang TL; Shih IM
Am J Surg Pathol; 2024 Apr; 48(4):475-486. PubMed ID: 38298022
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Characteristics of Unsuspected Neoplasia Discovered in High-Risk Women Undergoing Risk Reductive Bilateral Salpingooophorectomy.
Poon C; Hyde S; Grant P; Newman M; Ireland Jenkin K
Int J Gynecol Cancer; 2016 Oct; 26(8):1415-20. PubMed ID: 27488216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
